Ocular Therapeutix (OCUL) Other Non-Current Liabilities (2013 - 2026)

Ocular Therapeutix's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $909000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 531.25% year-over-year to $909000.0; the TTM figure through Mar 2026 stood at $909000.0 (up 531.25% YoY), while the FY2025 annual figure was $13.9 million, up 9760.28% from the prior year.
• Other Non-Current Liabilities was $909000.0 for Q1 2026 at Ocular Therapeutix, down from $13.9 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $30.0 million in Q4 2023 to a low of $117000.0 in Q3 2024.
• Historically, Other Non-Current Liabilities has averaged $10.6 million across 5 years, with a median of $11.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities plunged 99.53% in 2024, then surged 12688.03% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $6.4 million in 2022, then jumped by 372.16% to $30.0 million in 2023, then slumped by 99.53% to $141000.0 in 2024, then soared by 9760.28% to $13.9 million in 2025, then tumbled by 93.46% to $909000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $909000.0 (Q1 2026), $13.9 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.